Navigation Links
BioMarin Provides Update on GALNS Phase 1/2 Extension Study (MOR-100)
Date:7/28/2011

Lysosomal Storage Disease conference in February 2012.  

Highlights of MOR-100 Extension Study:

  • No new or consistent patterns of clinically meaningful or treatment limiting adverse events were reported.  
  • Measures of 6-minute walk distance, 3-minute stair climb and pulmonary function all generally improved and were sustained for at least 2 years.
  • For the group of patients with baseline 6-minute walk distance <325 meters, mean walk distance remains consistently improved for the entire period of observation.  Specifically, 24 weeks after resuming 2.0 mg/kg/week dosing in MOR-100, the mean 6-minute walk distance was 38 meters.  This is roughly equivalent to that observed after the first 24 weeks of the original Phase 1/2 trial (MOR-002).  The ongoing Phase 3 study is using mean improvement in 6-minute walk distance in patients with baseline walk distance <325 meters as the primary endpoint.  
  • 6-minute walk distance improvements were greater in the subgroup of patients with baseline walk distance <325 meters.  However, variability of this test increases with longer-term follow-up, likely as a result of issues related to the progressive nature of Morquio syndrome. Several measures to reduce variability have already been incorporated in the ongoing Phase 3 trial: large sample size, selection of patients not expected to require surgical correction of skeletal deformity in the subsequent 24 weeks, duplicate measures of 6-minute walk test, conclusion of the trial at 24 weeks, extensive oversight of the performance of the walk test according to ATS criteria and inclusion of placebo for comparative purposes.
  • 3-minute stair climb and pulmonary function have consistently improved over the entire duration of the study.  24 weeks after returning to 2.0 mg/kg, patients can now climb a mean of 13.6 stairs per minute and FVC has improved a mean of 15.9%, compared to 6.9 stairs per m
    '/>"/>

  • SOURCE BioMarin Pharmaceutical Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related biology technology :

    1. BioMarin Initiates Phase 1 Trial for BMN 673 in Patients With Advanced Hematological Malignancies
    2. BioMarin to Present at the UBS Global Specialty Pharmaceuticals Conference
    3. BioMarin to Host First Quarter 2011 Financial Results Conference Call and Webcast on Thursday, April 28 at 5:00 p.m. ET
    4. BioMarin to Host Third Quarter 2010 Financial Results Conference Call and Webcast on Thursday, October 28 at 5:00 p.m. ET
    5. BioMarin to Present at the Barclays Capital Global Healthcare Conference
    6. BioMarins Chief Executive Jean-Jacques Bienaime to Receive Most Admired CEO Award From San Francisco Business Times
    7. BioMarin to Host Third Quarter 2009 Financial Results Conference Call and Webcast on Wednesday, October 28 at 5:00 p.m. ET
    8. BioMarin to Present at the Morgan Stanley Healthcare Conference
    9. BioMarin to Present at the Baird Healthcare Conference
    10. BioMarin to Present at the Jefferies Healthcare Conference
    11. BioMarin to Present at the Goldman Sachs Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire/ - iCo Therapeutics ... today reported financial results for the six months ... are expressed in Canadian dollars and presented under ... Quarter 2014 Highlights , Announced top-line ... (VA) primary endpoint for subjects enrolled in the ...
    (Date:8/29/2014)... Due to a misstatement posted by the ... Cell Technology Center, LLC ( ASCTC ) was reported as ... that might benefit ALS patients. Because of ASCTC's exclusive ... technologies and therapeutic applications, FRC listed ASCTC as one of ... who wish not to support research that requires the death ...
    (Date:8/28/2014)... (PRWEB) August 28, 2014 SPIE Fellow ... Physics and Optical Science and Director of the Center ... North Carolina at Charlotte, and co-founder and Chairman of ... serve as the 2015 Vice President of SPIE, the ... President Philip Stahl announced recent election results at the ...
    (Date:8/28/2014)... “This kit has an improved extraction efficiency and provides users ... said Mark Tess, PhD, Mycotoxin Product Manager for Charm Sciences. ... USDA-GIPSA inspection agencies that have a need to detect aflatoxin ... a matter of minutes with nothing but our equipment and ... grain before accepting it, but they no longer have to ...
    Breaking Biology Technology:iCo Therapeutics Announces Second Quarter 2014 Financial Results 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 3iCo Therapeutics Announces Second Quarter 2014 Financial Results 4The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 3Glenn Boreman, UNC Professor and Plasmonics Co-Founder, Elected to SPIE Presidential Chain 2
    ... SAN DIEGO, Jan. 13 NexBio, a privately held ... that David Wurtman, MD, MBA, Vice President of Corporate ... 2009 Biotech Showcase in San Francisco, CA, on January ... to save lives and to improve the quality of ...
    ... BOSTON, Jan. 13 Johnston Blakely & Company, ... to announce that Michael,D. Webb has joined the ... Mr. Webb will,participate with the firm on internal ... and private equity placements, with a,particular focus on ...
    ... HOPE, Pa., Jan. 13 Jubilant Organosys,Ltd., ... today that its,Bangalore-based subsidiary, Jubilant Biosys Ltd., ... BioLeap, LLC, USA. Under this partnership, ... computational fragment,based drug design platform with Jubilant,s ...
    Cached Biology Technology:NexBio to Present at 2009 Biotech Showcase 2NexBio to Present at 2009 Biotech Showcase 3Jubilant and BioLeap Announce New Partnership in Drug Discovery 2Jubilant and BioLeap Announce New Partnership in Drug Discovery 3
    (Date:8/29/2014)... Kansas City, MO. - In a cell,s nucleus, ... known as histones, an amalgam biologists call chromatin. ... as a nuclear "sidekick," the mere packing material ... Recently, however, biologists have developed a greater appreciation ... In 2012, investigators from multiple research institutions studying ...
    (Date:8/28/2014)... America (ESA) is pleased to announce the selection of ... Society. Honorary Membership acknowledges those who have served ESA ... the affairs of the Society that has reached an ... the ESA Governing Board and then voted on by ... the Awards Ceremony at Entomology 2014, ESA,s Annual Meeting ...
    (Date:8/28/2014)... traditional cigarettes, but still release toxins into the ... , Scientists studying secondhand smoke from e-cigarettes discovered ... particles, with close-to-zero exposure to organic carcinogens. However, ... second-hand e-cigarette smoke were found to be significantly ... of polycyclic aromatic hydrocarbons cancer-causing organic compounds ...
    Breaking Biology News(10 mins):'K-to-M' histone mutations: How repressing the repressors may drive tissue-specific cancers 2'K-to-M' histone mutations: How repressing the repressors may drive tissue-specific cancers 3Fred Baxendale selected as Honorary Member of the Entomological Society of America 2Second-hand e-cig smoke compared to regular cigarette smoke 2
    ... A team of researchers, led by biologists at Dartmouth, ... in Lake Baiyangdian, the largest lake in the North ... drinking water for the people who live around it. ... Lake Baiyangdian, all at varying distances from major sources ...
    ... Is getting new knees on your list of New ... indicates that women wait longer to pursue knee-replacement surgery ... can no longer stand the pain, these women may ... on hold indefinitely, according to Lynn Snyder-Mackler, Distinguished Alumni ...
    ... If youre worried about high cholesterol levels and keeping ... and eggs just yet. A new study says they ... University have discovered that lower cholesterol levels can actually ... assistant professor of health and kinesiology, and Simon Sheather, ...
    Cached Biology News:Dartmouth researchers alarmed by levels of mercury and arsenic in Chinese freshwater ecosystem 2Listen-up ladies: Don't postpone knee-replacement surgery 2Listen-up ladies: Don't postpone knee-replacement surgery 3Surprise -- cholesterol may actually pose benefits, study shows 2
    Natural Mouse Laminin is purified from the Engelbreth-Holm-Swarm (EHS) sarcoma and is provided in Tris-buffered saline....
    EPH electrode, cathode, 1. Category: Electrophoresis Systems & Standards & Reagents, IEF & SDS-PAGE & 2-D Electrophoresis, Multiphor II Kits & Components and Accessories....
    ... paraffin tissue array is designed for ... interest in extensive panels of different ... heart, kidney, liver, lung, muscle, spleen ... positively charged glass slide. Each ...
    Rat Normal Multiple Tissue Array 1 slide...
    Biology Products: